182 related articles for article (PubMed ID: 23670820)
1. Isolated cerebral susceptibility artefacts in patients with malignant melanoma: metastasis or not?
Gramsch C; Göricke SL; Behrens F; Zimmer L; Schadendorf D; Krasny A; Forsting M; Schlamann MU
Eur Radiol; 2013 Sep; 23(9):2622-7. PubMed ID: 23670820
[TBL] [Abstract][Full Text] [Related]
2. Intracranial metastatic melanoma: correlation between MR imaging characteristics and melanin content.
Isiklar I; Leeds NE; Fuller GN; Kumar AJ
AJR Am J Roentgenol; 1995 Dec; 165(6):1503-12. PubMed ID: 7484597
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility-weighted imaging in malignant melanoma brain metastasis.
Schwarz D; Niederle T; Münch P; Hielscher T; Hassel JC; Schlemmer HP; Platten M; Winkler F; Wick W; Heiland S; Delorme S; Bendszus M; Bäumer P; Breckwoldt MO
J Magn Reson Imaging; 2019 Oct; 50(4):1251-1259. PubMed ID: 30793419
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Melanin Content and its Influence on Susceptibility Contrast in Melanoma Metastases.
Straub S; Laun FB; Freitag MT; Kölsche C; von Deimling A; Denoix M; Bendszus M; Schlemmer HP; Ladd ME; Schneider TM
Clin Neuroradiol; 2020 Sep; 30(3):607-614. PubMed ID: 31396654
[TBL] [Abstract][Full Text] [Related]
5. Improved detection of metastatic melanoma by T2*-weighted imaging.
Gaviani P; Mullins ME; Braga TA; Hedley-Whyte ET; Halpern EF; Schaefer PS; Henson JW
AJNR Am J Neuroradiol; 2006 Mar; 27(3):605-8. PubMed ID: 16552002
[TBL] [Abstract][Full Text] [Related]
6. [Cerebral MR imaging of malignant melanoma].
Breckwoldt M; Bendszus M
Radiologe; 2015 Feb; 55(2):113-9. PubMed ID: 25589420
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of different MRI sequences in the early detection of melanoma brain metastases.
Deike-Hofmann K; Thünemann D; Breckwoldt MO; Schwarz D; Radbruch A; Enk A; Bendszus M; Hassel J; Schlemmer HP; Bäumer P
PLoS One; 2018; 13(3):e0193946. PubMed ID: 29596475
[TBL] [Abstract][Full Text] [Related]
8. Serial MR imaging of intracranial metastases after radiosurgery.
Hawighorst H; Essig M; Debus J; Knopp MV; Engenhart-Cabilic R; Schönberg SO; Brix G; Zuna I; van Kaick G
Magn Reson Imaging; 1997; 15(10):1121-32. PubMed ID: 9408133
[TBL] [Abstract][Full Text] [Related]
9. Imaging of brain metastases of bronchial carcinomas with 7 T MRI - initial results.
Mönninghoff C; Maderwald S; Theysohn JM; Schütt P; Gauler T; Kraff O; Ladd ME; Ladd SC; Wanke I
Rofo; 2010 Sep; 182(9):764-72. PubMed ID: 20544578
[TBL] [Abstract][Full Text] [Related]
10. Cerebral metastatic malignant melanoma: CT and MR findings with pathological correlation.
Dewulf P; Demaerel P; Wilms G; Delanote G; Defloor E; Casselman J; Baert AL
J Belge Radiol; 1993 Oct; 76(5):318-9. PubMed ID: 8119873
[TBL] [Abstract][Full Text] [Related]
11. Intracerebral malignant melanoma: high-field-strength MR imaging.
Woodruff WW; Djang WT; McLendon RE; Heinz ER; Voorhees DR
Radiology; 1987 Oct; 165(1):209-13. PubMed ID: 3628773
[TBL] [Abstract][Full Text] [Related]
12. [Comparative evaluation of computerized tomography/magnetic resonance (1.5 T) in the detection of brain metastasis].
Golfieri R; Cherryman GR; Olliff JF; Husband JE
Radiol Med; 1991; 82(1-2):27-34. PubMed ID: 1654578
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enhanced MR imaging.
Davis PC; Hudgins PA; Peterman SB; Hoffman JC
AJNR Am J Neuroradiol; 1991; 12(2):293-300. PubMed ID: 1902031
[TBL] [Abstract][Full Text] [Related]
14. Visceral metastases from melanoma: findings on MR imaging.
Premkumar A; Sanders L; Marincola F; Feuerstein I; Concepcion R; Schwartzentruber D
AJR Am J Roentgenol; 1992 Feb; 158(2):293-8. PubMed ID: 1729784
[TBL] [Abstract][Full Text] [Related]
15. Computed tomography and magnetic resonance imaging of nonhemorrhagic, metastatic melanoma of the brain--case report.
Uozumi A; Saegusa T; Ohsato K; Yamaura A
Neurol Med Chir (Tokyo); 1990 Feb; 30(2):143-6. PubMed ID: 1695337
[TBL] [Abstract][Full Text] [Related]
16. Pyogenic hepatic abscesses: MRI findings on T1- and T2-weighted and serial gadolinium-enhanced gradient-echo images.
Balci NC; Semelka RC; Noone TC; Siegelman ES; de Beeck BO; Brown JJ; Lee MG
J Magn Reson Imaging; 1999 Feb; 9(2):285-90. PubMed ID: 10077026
[TBL] [Abstract][Full Text] [Related]
17. Malignant lesions of the liver with high signal intensity on T1-weighted MR images.
Kelekis NL; Semelka RC; Woosley JT
J Magn Reson Imaging; 1996; 6(2):291-4. PubMed ID: 9132092
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses.
Sehgal V; Delproposto Z; Haddar D; Haacke EM; Sloan AE; Zamorano LJ; Barger G; Hu J; Xu Y; Prabhakaran KP; Elangovan IR; Neelavalli J; Reichenbach JR
J Magn Reson Imaging; 2006 Jul; 24(1):41-51. PubMed ID: 16755540
[TBL] [Abstract][Full Text] [Related]
19. Use of Susceptibility-Weighted Imaging (SWI) in the Detection of Brain Hemorrhagic Metastases from Breast Cancer and Melanoma.
Franceschi AM; Moschos SJ; Anders CK; Glaubiger S; Collichio FA; Lee CB; Castillo M; Lee YZ
J Comput Assist Tomogr; 2016; 40(5):803-5. PubMed ID: 27636126
[TBL] [Abstract][Full Text] [Related]
20. Influence of paramagnetic melanin on the MRI contrast in melanoma: a combined high-field (11.7 T) MRI and EPR study.
Godechal Q; Mignion L; Karroum O; Magat J; Danhier P; Morandini R; Ghanem GE; Leveque P; Gallez B
Contrast Media Mol Imaging; 2014; 9(2):154-60. PubMed ID: 24523060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
